The Clorox Company (NYSE:CLX) Shares Purchased by Sanctuary Advisors LLC

Sanctuary Advisors LLC raised its holdings in The Clorox Company (NYSE:CLX) by 9.2% during the third quarter, HoldingsChannel reports. The firm owned 22,102 shares of the company’s stock after buying an additional 1,864 shares during the period. Sanctuary Advisors LLC’s holdings in Clorox were worth $3,742,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in CLX. Prospera Private Wealth LLC purchased a new position in shares of Clorox in the 3rd quarter valued at approximately $27,000. Innealta Capital LLC acquired a new stake in shares of Clorox during the second quarter worth $30,000. Trifecta Capital Advisors LLC grew its position in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the last quarter. Continuum Advisory LLC increased its stake in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the period. Finally, Family Firm Inc. purchased a new position in Clorox during the 2nd quarter worth $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Clorox stock opened at $164.40 on Tuesday. The firm has a market capitalization of $20.35 billion, a PE ratio of 57.28, a P/E/G ratio of 3.04 and a beta of 0.42. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The firm’s 50-day simple moving average is $163.84 and its 200 day simple moving average is $152.11. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm earned $0.49 earnings per share. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. On average, equities research analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 2.97%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 170.03%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on CLX. Barclays lifted their target price on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Evercore ISI cut their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. JPMorgan Chase & Co. increased their price objective on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Finally, DA Davidson boosted their target price on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, Clorox has an average rating of “Hold” and an average target price of $155.38.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.